Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort

Evolution of antibody immunity to SARS-CoV-2

(2021) Christian Gaebler et al.   NATURE

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

(2021) Aurélien Sokal et al.   CELL

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2

(2021) Saman Saadat et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

(2021) Charlotte Manisty et al.   LANCET

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine

(2021) Maria Prendecki et al.   LANCET

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

(2021) Florian Krammer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection

(2021) Federico Gobbi et al.   Viruses-Basel

Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities

(2021) Maria G. Noval et al.   Scientific Reports

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

(2021) Venkata Viswanadh Edara et al.   Cell Host & Microbe

SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors

(2021) Evangelos Terpos et al.   European Journal of Internal Medicine

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination

(2021) Rishi R. Goel et al.   Science Immunology

Antibody and B cell responses to SARS-CoV-2 infection and vaccination

(2021) Katharina Röltgen et al.   Cell Host & Microbe

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

(2021) Frauke Muecksch et al.   IMMUNITY

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

(2021) Saya Moriyama et al.   IMMUNITY

The who international standard for covid-19 serological tests: towards harmonization of anti-spike assays

(2021) Maria Infantino et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection

(2021) Juan P. Wisnivesky et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

(2021) Zijun Wang et al.   NATURE

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

(2021) Dan H. Barouch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

(2021) Anu Haveri et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries

(2021) Asim Hussain et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

(2020) Tran Thi Nhu Thao et al.   NATURE

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding

(2020) Lauren E. Gentles et al.   Viruses-Basel

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Bo Diao et al.   Frontiers in Immunology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review

(2020) Wei Feng et al.   Molecular Cancer

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

(2020) Anita S. Iyer et al.   Science Immunology

Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection

(2020) Annabelle Strömer et al.   Microorganisms

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

(2020) Carlo Cervia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology